Illumina is cash-rich, yet it continues to cut employee RSUs, benefits, and jobs—not because it lacks funds to reinvest in R&D, but because its CEO and CFO behave like career executives rather than visionary leaders. They run the company like accountants, prioritizing Wall Street expectations, margin commitments, and potentially their own margin-linked stock compensation over employees, innovation, and long-term growth.
There are no replies in this thread yet. Be the first to post a reply below: